Developing a European Market Access Strategy and Plan
Client: A newly established Pharmaceutical Company
Challenge
The Head of International Business commissioned Decisive to construct and lead a Market Access Plan for Europe
A 6-month gap was anticipated prior to the hiring of an EU Market Access Leader
EMA filing was less than 12 months away
Approach
We developed a roadmap for EU Pricing and reimbursement, identifying key gaps in current insight and commercial plans
We designed mitigations for key gaps and ran RFP processes to appoint strategic vendors to deliver
We designed and ran a series of Payer/Clinical Advisory Boards across Priority Countries to deepen insight and pressure-test value proposition
Result
Client testimonial:
“Decisive has helped our European launch effort in leading our market access activities across the continent. The company has proven to be a dynamic partner that brings a wealth of experience in launching innovative and niche biotechnology products to market in a complex reimbursement environment. I highly recommend Decisive as a partner for growing biotechnology companies looking to make an impact in Europe.”